| Name | Title | Contact Details |
|---|
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
Accent Plastic Surgery Pa is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Patient Funding Alternatives is a company that specializes in identifying, tracking, and helping Medicaid patients and families access healthcare funding options. They work with hospitals and other providers to make revenue processes smarter.
Roche Diagnostics - Div. de is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ameriplan is a Foley, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.